AzTrials
AzTrials

Healthy SubjectsNCT06181149

Auditory Prediction and Error Evaluation in the Speech of Individuals Who Stutter

A study testing Delaying speech initiation, Auditory errors and pre-speech auditory modulation and Contributions of the speech premotor cortex to pre-speech auditory modulation in people with Healthy Subjects and Stuttering, Developmental, run by Arizona State University at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Stuttering negatively impacts communication and reduces the overall quality of life and well-being of individuals who stutter. This study will provide a strong foundation for developing neural and behavioral interventions for stuttering. Read more about this study

Who is it for?
Ages 3 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy Subjects, Stuttering, Developmental
What is being tested?
Delaying speech initiation, Auditory errors and pre-speech auditory modulation and Contributions of the speech premotor cortex to pre-speech auditory modulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
2 sitesUnited States
Study dates
1 Jan 2024to 30 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • being a monolingual, native speaker of American English
  • absence of developmental, psychological, neurological, or communication disorders (other than developmental stuttering) as confirmed by a certified research SLP
  • normal (age-appropriate) binaural pure-tone hearing threshold (0.5-4k Hz; ≤25 dB HL for younger than 70 years, and ≤35 dB HL for older than 70 years)
  • not taking any medications that affect the central nervous system
  • absence of safety contra-indication for tDCS, TMS and MRI (for adults)
  • scoring at the 20th percentile or higher on standardized speech-language tests (for children)

Who cannot join

  • -

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Ayoub Daliri, PhD contact

4807278397

ayoub.daliri@asu.edu

United States2 sites, 2 recruiting
  • Univeristy of Washington

    Seattle, Washington, 98105

    Ludo Max, 206-543-2674, LudoMax@uw.edu

    Ludo Max, PhD

    Recruiting
  • Arizona State University

    Tempe, Arizona, 85287

    Ayoub Daliri, 480-727-8397, ayoub.daliri@asu.edu

    Ayoub Daliri, PhD

    Recruiting

Other trials in United States

About this study

Stuttering negatively impacts communication and reduces the overall quality of life and well-being of individuals who stutter. This study will provide a strong foundation for developing neural and behavioral interventions for stuttering. Participants will be asked to name pictures, read words/sentences silently or aloud, and listen to speech and nonspeech sounds while their speech, muscle, and brain signals are collected. Some participants may also receive brain stimulation while reading and speaking.

Being tested
Delaying speech initiation, Auditory errors and pre-speech auditory modulation, Contributions of the speech premotor cortex to pre-speech auditory modulation, Delaying auditory feedback
Keywords
stuttering
Medical subject headings
Stuttering

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Delaying speech initiationBehavioural

    This intervention will examine the effects of misalignment between prediction and auditory feedback in participants. We will use transcranial magnetic stimulation to induce a temporal misalignment between prediction and auditory feedback while participants produce speech.

  • Auditory errors and pre-speech auditory modulationBehavioural

    This intervention will examine the contributions of auditory errors to pre-speech auditory modulation. Participants will receive auditory perturbations while speaking, and we will collect their brain activities throughout the study.

  • Contributions of the speech premotor cortex to pre-speech auditory modulationBehavioural

    This intervention will examine the effects of stimulation of the left ventral premotor cortex on pre-speech auditory modulation. Participants will receive electrical stimulation while speaking.

  • Delaying auditory feedbackBehavioural

    This intervention will examine the effects of misalignment between prediction and auditory feedback in participants. We will use delayed auditory feedback to induce a temporal misalignment between prediction and auditory feedback while participants produce speech.

Study groups in NCT06181149
Study groupRoleWhat they receive
Group 1ExperimentalNot described
Receives: Behavioral: Delaying speech initiation
Group 2ExperimentalNot described
Receives: Behavioral: Auditory errors and pre-speech auditory modulation
Group 3ExperimentalNot described
Receives: Behavioral: Contributions of the speech premotor cortex to pre-speech auditory modulation
Group 4ExperimentalNot described
Receives: Behavioral: Delaying auditory feedback

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in brain activity before and during speaking

    Participants will hear speech sounds in each trial before speaking or reading words. Participants' brain activity will be recorded while completing the speaking or reading tasks. The investigators will measure how the participant's brain activity in response to the played sounds changes during speaking and reading tasks. For this purpose, the investigators will measure the amplitude of the brain activity (in microvolts; µV) measured using a commercial electroencephalography system. The amplitude (µV) of the brain signals will be examined both before speaking and during speaking at two time points.

    Measured: within each session of the study that may last up to 2 hours

  2. change in speech when participants experience auditory errors

    In each trial, participants will experience an auditory error while they produce speech (e.g., they may say "head" but hear "had"). The investigators will measure how the participants' speech changes due to auditory errors that they experience in the current trial. For this p[purpose, the investigators will use commercial microphones to record speech signals and then examine the amplitude of the speech in specific frequency ranges (measured in Hertz; Hz). The frequencies (Hz) of speech in trials with auditory errors will be compared with those without auditory errors.

    Measured: within each session of the study that may last up to 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Dec 2023
  2. Study start1 Jan 2024
  3. Primary completion30 Dec 2027 (estimated)
  4. Study completion30 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06181149
Sponsor's protocol ID
R01DC020162
Other IDs
1R01DC020162-01A1
Status last verified
Aug 2025
First submitted
7 Dec 2023
Last updated
21 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Delaying speech initiation, Auditory errors and pre-speech auditory modulation and Contributions of the speech premotor cortex to pre-speech auditory modulation in people with Healthy Subjects and Stuttering, Developmental, run by Arizona State University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ayoub Daliri, PhD (4807278397, ayoub.daliri@asu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in brain activity before and during speaking (time frame: within each session of the study that may last up to 2 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in